A hybrid model that combines reps with digital solutions is a win-win for pharmaceutical companies and GPs. With face-to-face rep engagement returning to pre-COVID levels, pharmaceutical companies have an opportunity to use digital lessons learned during the pandemic to significantly increase the reach and frequency of their GP interactions without increasing their budget. The solution
Building an opted-in HCP database and attracting HCPs to sign up to microsites is an ongoing challenge for pharmaceutical companies. This campaign illustrates the cost effectiveness of digital engagement solutions such as Access.PLUS to successfully drive APHRA-verified HCP sign-ups.
Black Dog Institute, a leading university-based mental health research institute asked ADG to promote its Working Towards Wellbeing training video series. The aim was to encourage best-practice mental health treatment options.
About one in three Australian GPs is a digital native,1 which has fundamental implications for go-to-market strategies and a critical impact on how pharmaceutical companies promote the quality use of their medicines. Digital natives were born after 1980 and raised in an environment in which they were surrounded by technology (Palfrey and Gasser, 2013, Prensky, 2001).
Australian prescribers have tasted digital convenience and are unlikely to return to their pre-pandemic levels of face-to-face engagement with pharmaceutical representatives. That’s according to an in-depth report published by ADG in 2021 and a follow-up pulse survey among Australian Doctor readers conducted in January 2022[i]. The report titled How a GP initiated engagement model could
With over 82% of GPs[1] and 90% of pharma sales reps, adg Rep Connect will soon become the largest and most powerful communications platform for doctors and pharmaceutical sales representatives wishing to communicate with each other. To continue to support doctors with getting access to the information they need, we are making some new changes
Being a member of the academic elite doesn’t necessarily make a good doctor, an AusDoc survey has revealed. From an experienced doctor’s perspective, high-achieving academics can face problems in practice. “Almost only the academic elite enter the system. This doesn’t necessarily make the best doctors…they are not used to failure and uncertainty and the hospital,
COVID-19 modelling expert explains why it’s going to be trickier than many people think to vaccinate ourselves out of Delta Even as vaccination rates rise across Australia, it is unlikely that risk-averse medical practices will be allowing pharmaceutical reps to engage in face-to-face visits any time soon. So how can new digital GTM channels help to close this gap? The only certainty
A leading pharmaceutical company asked ADG to design a campaign encouraging GPs to follow updated treatment guidelines and build their knowledge and confidence to initiate prescriptions of its product.
Research study reveals GP registrars carry heavy burden of responsibility without life experience to rely on, and tools pharma can use to help GP registrars are under such stress that they are seeking out peers and crowd support to help them feel more confident in their jobs, an AusDoc survey has revealed. The Project Pathway
Meet John Betsis from the Gold Coast, diagnosed with mitochondrial disease in his late teens.
Research study shows how to better support and educate this crucial market GPs are expected to stay up-to-date with the constant changes in medicine yet, with the myriad information available, they must still navigate and interrogate multiple sources to find what they need. This information overload takes time away from the main source of GPs’ job